Versor Investments’s Avanos Medical AVNS Stock Holding History

Versor Investments’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,600	Closed	-$186K	–	87
2025 Q4	$186K	Buy	+16,600	New	+$190K	0.03%	569
2025 Q1	–	Sell	-12,620	Closed	-$201K	–	703
2024 Q4	$201K	Sell	12,620 -2,680	-18%	-$53K	0.03%	690
2024 Q3	$368K	Buy	+15,300	New	+$350K	0.06%	524
2023 Q2	–	Sell	-7,144	Closed	-$212K	–	625
2023 Q1	$212K	Sell	7,144 -7,300	-51%	-$212K	0.03%	618
2022 Q4	$391K	Sell	14,444 -11,145	-44%	-$273K	0.03%	425
2022 Q3	$557K	Sell	25,589 -4,514	-15%	-$118K	0.03%	409
2022 Q2	$823K	Buy	30,103 +22,400	+291%	+$644K	0.03%	317
2022 Q1	$258K	Buy	7,703 +69	+0.9%	+$2.22K	0.01%	526
2021 Q4	$265K	Buy	7,634 +34	+0.4%	+$1.1K	0.01%	437
2021 Q3	$237K	Buy	+7,600	New	+$258K	0.01%	440

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Versor Investments's AVNS Position: Q1 2026 in Review

Versor Investments sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 16,600 shares — an estimated $186K sold.

Versor Investments first reported a position in AVNS in Q3 2021 and held it in 10 quarters. The position peaked at $823K in Q2 2022. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Versor Investments reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
Versor Investments sold 16,600 Avanos Medical shares in Q1 2026, an estimated $186K.
Versor Investments first reported a position in Avanos Medical in Q3 2021 and held it in 10 quarters.
Versor Investments's Avanos Medical position peaked at $823K in Q2 2022.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.